Related Experiment Video
Updated: May 15, 2026

Endoscopic Third Ventriculostomy and Pineal Biopsy from a Single Entry Point
Published on: June 28, 2024
An update on the management of pseudotumor cerebri
Michael A Galgano1, Eric M Deshaies
1Department of Neurosurgery, SUNY Upstate Medical University, Syracuse, NY, USA.
Insights
Pseudotumor cerebri (benign intracranial hypertension) causes disabling headaches and vision loss. Treatment options include medications, surgery, and endovascular venous stent placement for dural sinus issues.
Area of Science:
- Neurology
- Neurosurgery
- Vascular Neurology
Background:
- Pseudotumor cerebri (PTC), or benign intracranial hypertension (BIH), presents as increased intracranial pressure of unknown cause.
- It predominantly affects obese women under 45, causing debilitating headaches and visual disturbances.
- Medical management aims to reduce intracranial pressure (ICP) via CSF production inhibitors or volume reduction.
Purpose of the Study:
- To review the clinical presentation of pseudotumor cerebri.
- To discuss medical, surgical, and endovascular treatment modalities for PTC.
- To educate readers on the pathophysiology and management of BIH.
Main Methods:
- Review of clinical presentation and diagnostic criteria for PTC.
- Discussion of established medical treatments, including CSF production inhibitors and lumbar punctures.
- Exploration of surgical CSF diversion and emerging endovascular treatments like venous stenting.
Main Results:
- Dural sinus stenosis or thrombosis is increasingly recognized as a cause of PTC.
- Endovascular venous stent placement offers a novel treatment for PTC secondary to venous sinus abnormalities.
- Comprehensive management requires a multidisciplinary approach.
Conclusions:
- Pseudotumor cerebri management encompasses medical, surgical, and endovascular strategies.
- Identifying and treating underlying venous sinus pathology is crucial for refractory PTC cases.
- Understanding PTC pathophysiology guides effective therapeutic decision-making.
Abstract:
Pseudotumor cerebri, or benign intracranial hypertension, is characterized by intracranial hypertension of unknown etiology typically in obese women <45 years of age, and can be disabling secondary to headaches and visual disturbances. Medical management includes pharmaceuticals that reduce cerebrospinal fluid (CSF) production and lumbar punctures that reduce the CSF volume, both aimed at reducing intracranial pressure. When medical management fails, surgical CSF diverting procedures are indicated. Recently it has been demonstrated that dural sinus stenosis or thrombosis can be responsible for this disease and treated with endovascular venous stent placement. The intent of this educational manuscript is to review the clinical presentation of pseudotumor cerebri patients and discuss the medical, surgical, and endovascular treatment options for this disease. After reading this paper, the reader should be able to: (1) understand the pathophysiological basis of pseudotumor cerebri, (2) describe its presenting signs and symptoms, and (3) discuss the medical, surgical, and endovascular treatment options.
Related Concept Videos
Increased Intracranial Pressure l: Introduction
Brain Abscess l: Introduction
Increased Intracranial Pressure ll: Pathophysiology
Aneurysm IV: Nursing Management
Cerebral Edema ll: Pathophysiology
Psychosurgery
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...

